212 related articles for article (PubMed ID: 35274835)
1. An Update on the Laboratory Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Jeyalatha MV; Therese KL; Anand AR
J Clin Neurol; 2022 Mar; 18(2):152-162. PubMed ID: 35274835
[TBL] [Abstract][Full Text] [Related]
2. Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein IgG associated disorder: A comprehensive neuro-ophthalmic review.
Sharma J; Bhatti MT; Danesh-Meyer HV
Clin Exp Ophthalmol; 2021 Mar; 49(2):186-202. PubMed ID: 33426799
[TBL] [Abstract][Full Text] [Related]
3. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
[TBL] [Abstract][Full Text] [Related]
4. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
5. [From neuromyelitis optica to neuromyelitis optica spectrum disorder: from clinical syndrome to diagnistic classification].
Aktas O; Kümpfel T
Nervenarzt; 2021 Apr; 92(4):307-316. PubMed ID: 33728474
[TBL] [Abstract][Full Text] [Related]
6. Controversies in the management of neuromyelitis optica spectrum disorder.
Bruscolini A; La Cava M; Mallone F; Marcelli M; Ralli M; Sagnelli P; Greco A; Lambiase A
Expert Rev Neurother; 2019 Nov; 19(11):1127-1133. PubMed ID: 31339052
[No Abstract] [Full Text] [Related]
7. Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review.
Ferilli MAN; Paparella R; Morandini I; Papetti L; Figà Talamanca L; Ruscitto C; Ursitti F; Moavero R; Sforza G; Tarantino S; Proietti Checchi M; Vigevano F; Valeriani M
Life (Basel); 2021 Dec; 12(1):. PubMed ID: 35054412
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica spectrum disorders: Features of aquaporin-4, myelin oligodendrocyte glycoprotein and double-seronegative-mediated subtypes.
Alves Do Rego C; Collongues N
Rev Neurol (Paris); 2018 Jun; 174(6):458-470. PubMed ID: 29685427
[TBL] [Abstract][Full Text] [Related]
9. Pathobiology, Diagnosis, and Current Biomarkers in Neuromyelitis Optica Spectrum Disorders.
Fiala C; Rotstein D; Pasic MD
J Appl Lab Med; 2022 Jan; 7(1):305-310. PubMed ID: 34996075
[TBL] [Abstract][Full Text] [Related]
10. Seronegative Neuromyelitis Optica Spectrum--the challenges on disease definition and pathogenesis.
Sato DK; Callegaro D; Lana-Peixoto MA; Nakashima I; Fujihara K
Arq Neuropsiquiatr; 2014 Jun; 72(6):445-50. PubMed ID: 24964112
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of neuromyelitis optica spectrum disorders - An update.
Bruscolini A; Sacchetti M; La Cava M; Gharbiya M; Ralli M; Lambiase A; De Virgilio A; Greco A
Autoimmun Rev; 2018 Mar; 17(3):195-200. PubMed ID: 29339316
[TBL] [Abstract][Full Text] [Related]
12. Anti-MOG associated disorder-Clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience.
Rempe T; Tarhan B; Rodriguez E; Viswanathan VT; Gyang TV; Carlson A; Tuna IS; Rees J
Mult Scler Relat Disord; 2021 Feb; 48():102718. PubMed ID: 33388560
[TBL] [Abstract][Full Text] [Related]
13. Differential diagnosis of neuromyelitis optica spectrum disorders.
Kim SM; Kim SJ; Lee HJ; Kuroda H; Palace J; Fujihara K
Ther Adv Neurol Disord; 2017 Jul; 10(7):265-289. PubMed ID: 28670343
[TBL] [Abstract][Full Text] [Related]
14. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis].
Wei SH; Zhao Y
Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393
[TBL] [Abstract][Full Text] [Related]
15. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
17. Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler P; Grittner U; Oechtering J; Leppert D; Siebert N; Duchow AS; Oertel FC; Asseyer S; Kuchling J; Zimmermann HG; Brandt AU; Benkert P; Reindl M; Jarius S; Paul F; Bellmann-Strobl J; Kuhle J; Ruprecht K
J Neuroinflammation; 2021 May; 18(1):105. PubMed ID: 33933106
[TBL] [Abstract][Full Text] [Related]
18. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W
Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
[No Abstract] [Full Text] [Related]
20. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.
Dos Passos GR; Oliveira LM; da Costa BK; Apostolos-Pereira SL; Callegaro D; Fujihara K; Sato DK
Front Neurol; 2018; 9():217. PubMed ID: 29670575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
